Skip to main content
    C

    CNS Pharmaceuticals Inc (CNSP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.48
    +0.59 (+20.42%)

    Market Cap: $4.22M

    Last updated: Nov 17, 2026 at 10:56 AM ET

    CNS Pharmaceuticals Inc (CNSP) Earnings: Report Dates and Results

    Updated Aug 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    CNS Pharmaceuticals (CNSP) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, CNS Pharmaceuticals reported EPS of -$0.38, below the -$0.24 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    42%(10/24)
    Avg Surprise
    -53.55%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.28
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    CNSP has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 24 quarters below that had an estimate, CNSP beat 10 and missed 14. The widest gap in the table came in the quarter ended Dec 31, 2019, when EPS landed 466.67% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.38-$0.24-$0.24 - -$0.24-58.33%MissN/A10 up, 0 downAug 12, 2026
    Mar 31, 2026-$7.30-$5.37-$5.37 - -$5.37-35.94%MissN/A10 up, 0 downMay 14, 2026
    Dec 31, 2025-$10.15-$5.09-$5.09 - -$5.09-99.41%MissN/A10 up, 0 downMar 31, 2026
    Sep 30, 2025-$5.76-$6.63-$6.63 - -$6.63+13.12%BeatN/A10 up, 0 downNov 14, 2025
    Jun 30, 2025-$6.42-$9.60N/A+33.13%BeatN/AN/A0 up, 0 downAug 14, 2025
    Mar 31, 2025-$1.58-$2.00N/A+21.00%BeatN/AN/A0 up, 0 downMay 15, 2025
    Dec 31, 2024-$37.33-$7.33N/A-409.28%MissN/A10 up, 0 downMar 31, 2025
    Sep 30, 2024-$150.00-$60.00N/A-150.00%MissN/A10 up, 0 downNov 14, 2024
    Jun 30, 2024-$6.72N/AN/AN/AN/AN/AN/A0 up, 0 downAug 14, 2024
    Mar 31, 2024-$0.41N/AN/AN/AN/AN/AN/A0 up, 0 downApr 1, 2024
    Dec 31, 2023-$28,622.96N/AN/AN/AN/AN/AN/A0 up, 0 downMar 14, 2024
    Sep 30, 2023-$32,400.01-$51,900.02N/A+37.57%BeatN/AN/AN/ANov 14, 2023
    Jun 30, 2023-$31,200.01-$84,600.03N/A+63.12%BeatN/AN/AN/AAug 14, 2023
    Mar 31, 2023-$2.59N/AN/AN/AN/AN/AN/A0 up, 0 downMay 15, 2023
    Dec 31, 2022-$3.82-$2.40N/A-59.21%MissN/AN/A0 up, 0 downMar 31, 2023
    Sep 30, 2022-$81,000.11-$90,000.13N/A+10.00%BeatN/A10 up, 0 downNov 10, 2022
    Jun 30, 2022-$81,000.11-$72,000.10N/A-12.50%MissN/A10 up, 0 downAug 12, 2022
    Mar 31, 2022-$63,000.09-$126,000.18N/A+50.00%BeatN/A10 up, 0 downMay 16, 2022
    Dec 31, 2021-$3.00-$4.80-$6.31 - -$3.30+37.50%BeatN/A20 up, 0 downMar 3, 2022
    Sep 30, 2021-$126,000.18-$132,000.18-$189,264.90 - -$99,138.75+4.55%BeatN/A4N/ANov 12, 2021
    Jun 30, 2021-$135,000.19-$117,000.16-$144,201.82 - -$90,126.14-15.38%MissN/A2N/AAug 13, 2021
    Mar 31, 2021-$135,000.19-$108,000.15N/A-25.00%MissN/A2N/AMay 14, 2021
    Dec 31, 2020-$162,000.23-$105,750.15-$117,163.98 - -$81,113.53-53.19%MissN/A4N/AFeb 12, 2021
    Sep 30, 2020-$108,000.15-$112,500.16-$117,163.98 - -$108,151.37+4.00%BeatN/A2N/ANov 12, 2020
    Jun 30, 2020-$135,000.19-$72,000.10N/A-87.50%MissN/AN/AN/AAug 10, 2020
    Mar 31, 2020-$108,000.15-$90,000.13N/A-20.00%MissN/A1N/AMay 15, 2020
    Dec 31, 2019-$5.10-$0.90-$0.90 - -$0.90-466.67%MissN/A1N/AMar 12, 2020
    Sep 30, 2019-$45,000.06-$27,000.04N/A-66.67%MissN/A1N/ADec 20, 2019
    Jun 30, 2019-$0.03N/AN/AN/AN/AN/AN/AN/AAug 28, 2019
    Mar 31, 2019-$0.47N/AN/AN/AN/AN/AN/AN/AJun 28, 2019
    Last 30 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$23.91, after -$194.46 the year before. It was -$45,005.66 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$23.91N/A
    Dec 31, 2024-$194.46N/A
    Dec 31, 2023-$92,225.57N/A
    Dec 31, 2022-$225,004.13N/A
    Dec 31, 2021-$396,003.56N/A
    Dec 31, 2020-$513,000.72N/A
    Dec 31, 2019-$45,005.66N/A

    Frequently Asked Questions About CNSP

    When is CNS Pharmaceuticals's next earnings date?

    CNS Pharmaceuticals's next earnings report is expected for Mar 29, 2027.

    Did CNSP beat earnings estimates last quarter?

    No. CNS Pharmaceuticals reported EPS of -$0.38 for the quarter ended Jun 30, 2026, below the -$0.24 estimate by 58.33%.

    What EPS do analysts expect from CNSP next quarter?

    The consensus EPS estimate for CNS Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.28 from 3 analysts.

    How often does CNSP beat earnings estimates?

    CNS Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -85.71%.